Background
To date, more than 320 different human papillomavirus (HPV) types have been identified according to phylogenetic relationships of their complete L1 gene sequences, within five genera of the
Papillomaviridae family (
Alpha-,
Beta-,
Gamma-,
Mu- and
Nu-PV) [
1‐
3]. Based on the epithelial tissue tropism, HPVs have been originally subdivided into mucosal and cutaneous types [
1]. Mucosal HPV types, typically clustering to the
Alpha-PV genus, which also contains several predominantly cutaneous HPV types, are associated with the development of pre-malignant and malignant lesions of the anogenital, oral and oropharyngeal epithelia [
4].
Alpha-PV infections of the anal canal have frequently been detected in human immunodeficiency virus (HIV-1)-infected men who have sex with men (MSM) [
5,
6]. Moreover, HIV-1-positive MSM have approximately 60 times higher risk of developing anal cancer than the general population [
7,
8], and also show higher risk with respect to men who have sex with women (MSW) [
9], women [
10], and HIV-1-negative MSM [
11], but in lower proportions.
Cutaneous HPVs are dispersed across all five HPV genera and have most frequently been detected in healthy skin samples, suggesting their commensal nature [
2,
12]. However, several studies showed a high prevalence of
Beta- and
Gamma-PVs at several anatomical sites, different from sites in which they were originally identified, including cutaneous and mucosal lesions and healthy mucosa, suggesting their double, muco-cutaneous tissue tropism, and adding more questions about their clinical importance [
13‐
15]. In contrast to
Beta-PVs where the number of studies supporting their oncogenic potential in the development of skin cancer has increased over time [
16], the role of
Gamma-PVs in the development of malignant mucosal/cutaneous lesions has been poorly described [
17‐
19]. Interestingly, our recent study, together with previous data, suggests a potential active role of
Gamma-PVs in the development of pre-malignant skin lesions in immunocompetent individuals [
20,
21]. On the other hand, patients with a rare inherited immunodeficiency have been found to be uniquely susceptible to
Gamma-PV-associated skin warts [
22]. Furthermore, some
Gamma-PV types, especially those belonging to the
Gamma-6 species, have been detected in
Alpha-PV-negative anogenital warts [
23,
24] and cervical precancerous lesions [
13,
17,
18,
25,
26].
Even though the presence of different HPV types has recently been demonstrated in the anal canal of men, the used methodologies only enabled the identification of a limited number of
Alpha-,
Beta- and/or
Gamma-PV types [
5,
10,
27,
28]. Moreover, very little is known about the natural history of infection with predominantly cutaneous HPVs in the anogenital region [
27].
The objective of the present study was to assess the prevalence and type-specific distribution of a wide range of HPV types in a variety of mucosal samples, using a combination of two established broad-spectrum primer systems, enhancing the ability to detect Gamma-PVs. Additionally, the prevalence and persistence of HPV infection in the anal canal of HIV-1-positive and -negative men and women were comparatively evaluated.
Discussion
With the exception of
Alpha-PVs, which are etiologically associated with the development of more than 99% of cases of cervical cancer, 70–90% of cases of anal and vaginal cancers, 40% of cases of vulvar cancer, 47% of cases of penile cancer, 25-30% of cases of oropharyngeal cancer, and more than 90% of cases of genital warts and laryngeal papillomas [
37,
38], knowledge is limited concerning prevalence and clinical importance of other HPV genera in the mucosal epithelia. The present analysis of 458 mucosal samples, including biopsies of genital warts and cervical cancer as well as anal and oral swabs, enabled the identification of a large number of HPV types, clustering to a diverse range of species of
Alpha-,
Beta- and
Gamma-PV genera. Interestingly, only five HPV types were simultaneously detected by
Gamma-PV and CUT PCR assays, showing the differential capacities of both primer systems on detecting diverse HPV types, as indicated previously [
21]. Nevertheless that one set of broad-spectrum primers targeting the E1 gene has been described previously [
39], the mentioned CP primers can mostly detect
Alpha- and
Beta-PV types and have different specificities than those used in our
Gamma-PV assay (Table
S3).
Thirty-six different
Gamma-PVs, clustering into 18 species, with two of them described for the first time and not yet officially recognized (
Gamma-Un1,
Gamma-Un2; Fig.
2 and Table
S1), were identified in the present study. Among all
Gamma-PV-positive samples, members of the
Gamma-6 species were the most frequently detected (11/73; 15%). Interestingly, none of them were identified in a variety of 653 cutaneous samples with the same testing approach [
21]. These results, together with previously published findings [
13,
17,
26,
28,
40‐
43], suggest the possible adaptation of the mentioned HPV types to the mucosal epithelium [
44].
Our observations are not surprising since previous studies have demonstrated that typically cutaneous HPV types (
Beta- and
Gamma-PVs) were relatively common in the mucosal epithelia, suggesting a possible dual tissue tropism of the majority of HPV species [
1,
13,
32,
28,
45,
46]. In addition, two
Gamma-PV types were identified in a surface swab of a genital wart and a cervical cancer biopsy sample, possible as part of the normal mucosal microbiota, as reported previously [
23,
26].
Although using CUT primers several high- and low-risk
Alpha-PV types were identified in cervical cancer biopsies, a significantly lower HPV prevalence was found in the present study in comparison with previously published data [
4]. The mentioned discrepancy could be a result of the fact that CUT primers were designed to detect the so-called “cutaneous” HPV types that are distributed across all five HPV genera [
30]. Although CUT primers are able to detect mucosal types, their sensitivity for detection of
Alpha-PV is much lower in comparison to other approaches using well-known
Alpha-PV PCR primers, such as MY09/11, GP5+/6+ or SPF10, as previously reported [
47]. Therefore, the CUT primers are not recommended for detection of clinically most relevant mucosal
Alpha-PV HPV types associated with the development of several anogenital neoplasms, including cervical cancer. Instead, CUT primers can be considered as an additional tool for epidemiological studies, in combination with other testing approaches, such as the
Gamma-PV PCR assay and/or with standard
Alpha-PV primers, to explore the presence and HPV type diversity. Additionally, it should be considered that amplification of DNA sequences that are approximately 370 bp long could be compromised in FFPE tissue samples, leading to an underestimation of HPV prevalence.
In line with previous epidemiological studies that have analyzed the prevalence of HPV infection in anal canal of MSM [
5,
27,
28], MSW [
10] and women [
9], in the present study significantly higher overall HPV prevalence and rate of multiple HPV infections were detected in swabs of the anal canal of MSM in comparison to women (
p = 0.034 and
p = 0.003, respectively). Nevertheless that the prevalence of
Alpha-PV infections was similar in anal canal of MSM and women (
p = 0.515), interestingly, the prevalence of
Gamma-PVs was significantly higher among MSM (
p = 0.027). Although the mentioned differences may have originated from the use of different HPV detection methods in different studies, it is likely that receptive anal sexual intercourse might indeed have resulted from more frequent acquisition of
Gamma-PVs, as suggested previously for
Alpha- and
Beta-PVs [
27,
48,
49]. On the other hand, it should be considered that anal HPV infections, especially with
Beta- and
Gamma-PVs, may occur through self- or partner- inoculation [
50,
51].
In line with previous observations that younger age could be associated with the higher risk for acquiring anal HPV infection in men [
10,
52], in the present study significantly higher prevalence of multiple HPV infections was detected in subjects that were 18-30 and 31-40 years old at the time of the study in comparison to older individuals (41-66 years) (
p = 0.05). The age-specific HPV infection prevalence trends in the anogenital region may have resulted from younger subjects being more sexually active than older individuals, with up to 3-fold higher number of sexual partners [
52].
Since
Beta- and
Gamma-PV prevalence data among HIV-1-positive individuals are conflicting [
5,
27,
28,
41], HPV prevalence according to patients’ HIV-1 infection status was further investigated in the present study. In concordance with former reports [
28,
41], the prevalence of
Gamma-PVs and multiple HPV infections was significantly higher in HIV-1-positive subjects in comparison to HIV-1-negative individuals (
p = 0.003 and
p = 0.04, respectively). As the contradictory results obtained in epidemiological studies could be attributed to differences in the immune status of HIV-1-infected individuals and to the heterogeneity of enrolled patients and HPV detection methods used, additional studies are warranted to further explore the association(s) between HIV-1 and anal HPV infection.
Due to the scarce knowledge on the natural history of non-
Alpha-PV infection in the anal canal [
27], 21 patients were prospectively followed-up in our study. While all
Beta- and
Gamma-PV infections were found to be transient, a persistent
Alpha-PV infection was detected in one patient. Although transient
Gamma-PV infections have previously been described in healthy skin samples [
53], in studies using reverse-line blot hybridization techniques, it has been demonstrated that
Alpha- and
Beta-PVs can establish persistent infections of the anal canal [
11,
27]. It should be noted that in the present study, HPV infections were detected using broad-spectrum primers, enhancing the ability to amplify
Gamma-PVs, followed by direct sequencing of PCR products, which may represent a limitation, as it could have led to the underestimation of some HPVs causing persistent infections and being present in lower viral loads. Therefore, it is possible that
Gamma-PVs also cause transient infections of the anal canal, mostly having a commensal role and being transmitted through sexual and non-sexual routes.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.